HK1 and cancer: Furthermore, some metabolites that at low, physiological concentrations are innocuous, at high concentrations may become inhibitors of the controlling steps HK (Fru1,6BP) and HPI (dihydroxyacetone-phosphate; DHAP), inducing significant inhibition of the glycolytic flux in cancer cells (Moreno-Sánchez et al., 2016).